Merck & Co., Inc.

NYSE: MRK
$76.93
-$1.40 (-1.8%)
Closing price July 29, 2021
Two pharmaceutical companies and a top media firm are on tap to report quarterly results before markets open on Thursday.
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Tuesday, including Domino’s, Eli Lilly, Harley-Davidson, McDonald’s and Merck.
Among the stocks in Warren Buffett's Berkshire Hathaway portfolio are eight components of the Dow 30, and only three of those are in the green for the year to date.
Warren Buffett reduced Berkshire Hathaway's holdings in 13 stocks during the first quarter of this year. Here's how eight of those stocks have performed so far in the second quarter.
Investors can almost count on the taper tantrum selling when the Federal Reserve begins to slow the quantitative easing this year, and these five top Dow Jones industrials will be good stocks to be...
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including LendingTree, Merck, Micron Technology, Nvidia and Target.
Three of the four stocks in our Thursday morning earnings preview are components of the Dow Jones industrial average. The other is the third best-paying dividend stock among the S&P 500.
Wednesday's top analyst upgrades and downgrades included AbbVie, Alcoa, Anheuser Busch, Applied Materials, CyberArk, Fox, Merck, Paychex, ViacomCBS and Waste Management.
Here are five notable health care laggard stocks that appear to have plenty of upside potential. Most of them are dividend payers too.
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
The 2021 Dogs of the Dow are now known, and investors who may want to follow this investing strategy have got some thinking to do.
Six Dow stocks are on track to lose at least 10% of their value in 2020. Here's a look at what's happened.
One popular investment strategy, known as the Dogs of the Dow, has performed better than last year. What's ahead for the dogs in 2021?
Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may be one of the best ideas for 2021.
COVID-19 stocks were on the move on Wednesday after a few huge updates in regards to vaccine approval.